(RTTNews) - Haemonetics Corp. (HAE) said Friday it supports new guidance issued by the U.S. Food and Drug Administration or FDA related to the use of viscoelastic testing for the duration of the ...
BOSTON, April 2, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, ...
In this context, there have been significant advancements in hemostasis testing device technology. Leading surgical practices are now harnessing the power of next-generation viscoelastic testing (VET) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results